Ataxia telangiectasia associated with B-cell lymphoma: the effect of a half-dose of the drugs administered according to the acute lymphoblastic leukemia standard risk protocol. [electronic resource]
Producer: 19990107Description: 425-9 p. digitalISSN:- 0888-0018
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Ataxia Telangiectasia -- drug therapy
- Dose-Response Relationship, Drug
- Genes, Recessive
- Humans
- Infant
- Lymphoma, B-Cell -- drug therapy
- Male
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Remission Induction -- methods
- Risk Factors
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.